2-(1-ethoxyethyl)pyridine | 62369-31-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 英文名称: 2-(1-ethoxyethyl)pyridine
• 英文别名: Pyridine, 2-(1-ethoxyethyl)-
• CAS: 62369-31-7
• 化学式: C₉H₁₃NO
• 分子量: 151.208
• InChiKey: ISVCVTXNZCCDRU-UHFFFAOYSA-N

物化性质

• 沸点：
  79-80 °C(Press: 17 Torr)
• 密度：
  0.971±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.3
• 重原子数：
  11
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.44
• 拓扑面积：
  22.1
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  吡啶 、 乙醚 在 二叔丁基过氧化物 、 scandium tris(trifluoromethanesulfonate) 作用下， 反应 8.0h， 以58%的产率得到2-(1-ethoxyethyl)pyridine
  参考文献：
  名称：

  Highly Chemoselective and Regioselective Dehydrogenative Cross-Coupling Reaction between Pyridines and Ethers

  摘要：

  A highly chemoselective and regioselective dehydrogenative cross-coupling (DCC) reaction of unactivated pyridines with cyclic or acyclic ethers has been developed to give the corresponding 2- or 4-coupled pyridines in satisfactory yields. The DCC reaction affords an efficient and greener synthesis for a range of new pyridines. A possible mechanism involving radical substitution is also proposed.

  DOI：

  10.1055/s-0034-1380694

文献信息

• [EN] BICYCLIC HETEROCYCLIC COMPOUNDS AS INHIBITORS OFBCDIN3D ACTIVITY<br/>[FR] COMPOSÉS HÉTÉROCYCLIQUES BICYCLIQUES EN TANT QU'INHIBITEURS DE L'ACTIVITÉ DE BCDIN3D
  申请人：STORM THERAPEUTICS LTD

  公开号：WO2020254831A1

  公开（公告）日：2020-12-24

  The present invention relates to compounds that function as inhibitors and/or degraders of BCDIN3D activity. The present invention also relates to processes for the preparation of these compounds, to pharmaceutical compositions comprising them, and to their use in the treatment of proliferative disorders, such as cancer, as well as other diseases or conditions in which BCDIN3D activity is implicated.

  本发明涉及作为BCDIN3D活性抑制剂和/或降解剂的化合物。本发明还涉及制备这些化合物的方法，包括含有它们的药物组合物，以及它们在治疗增生性疾病，如癌症，以及其他BCDIN3D活性有所涉及的疾病或病况中的应用。
• NOVEL FUSED PYRAZOLE DERIVATIVES AND THEIR USE AS ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS
  申请人：Bolea Christelle

  公开号：US20130252944A1

  公开（公告）日：2013-09-26

  The present invention relates to novel compounds of Formula (I), wherein M, A and Y are defined as in Formula (I); invention compounds are modulators of metabotropic glutamate receptors—subtype 4 (“mGluR 4 ”) which are useful for the treatment or prevention of central nervous system disorders as well as other disorders modulated by mGluR 4 receptors. The invention is also directed to pharmaceutical compositions and the use of such compounds in the manufacture of medicaments, as well as to the use of such compounds for the prevention and treatment of such diseases in which mGluR 4 is involved.

  本发明涉及式(I)的新型化合物，其中M、A和Y如式(I)中所定义；发明化合物是代谢型谷氨酸受体亚型4（“mGluR4”）的调节剂，可用于治疗或预防中枢神经系统疾病以及其他受mGluR4受体调节的疾病。本发明还涉及制药组合物以及使用这种化合物制造药物的用途，以及使用这种化合物预防和治疗涉及mGluR4的疾病的用途。
• PYRIDONE COMPOUND, AND AGRICULTURAL AND HORTICULTURAL FUNGICIDE HAVING THIS AS ACTIVE COMPONENT
  申请人：Mitsui Chemicals Agro, Inc.

  公开号：EP3611164A1

  公开（公告）日：2020-02-19

  Novel compounds controlling plant diseases are provided. Pyridone compounds of the invention are novel and can control plant diseases. The pyridone compounds of the invention encompass compounds of formula (1) and salts thereof.

  本发明提供了控制植物病害的新型化合物。本发明的吡啶酮化合物很新颖，可以控制植物病害。本发明的吡啶酮化合物包括式（1）化合物及其盐类。
• Therapeutic compounds and uses thereof
  申请人：GENENTECH, INC.

  公开号：US10206931B2

  公开（公告）日：2019-02-19

  The present invention relates to compounds of formula (I): and to salts thereof, wherein A has any of the values defined in the specification, and compositions and uses thereof. The compounds are useful as inhibitors of CBP and/or EP300. Also included are pharmaceutical compositions comprising a compound of formula (I) or a pharmaceutically acceptable salt thereof, and methods of using such compounds and salts in the treatment of various CBP and/or EP300-mediated disorders.

  本发明涉及式（I）化合物： 及其盐，其中 A 具有说明书中定义的任一值，以及其组合物和用途。这些化合物可用作 CBP 和/或 EP300 的抑制剂。还包括包含式（I）化合物或其药学上可接受的盐的药物组合物，以及使用此类化合物和盐治疗各种CBP和/或EP300介导的疾病的方法。
• Gilbert, Andrew; Krestonosich, Stefan, Journal of the Chemical Society. Perkin transactions I, 1980, p. 2531 - 2534
  作者：Gilbert, Andrew、Krestonosich, Stefan

  DOI：——

  日期：——